BiotechTube
Home/Pipeline/af-003

af-003

Pan-Cancer

IND-enablingActive

Key Facts

Indication
Pan-Cancer
Phase
IND-enabling
Status
Active
Company
Alpha Fusion

About Alpha Fusion

A Japanese biotech developing targeted alpha therapies using Astatine-211 for precise cancer treatment with minimal side effects.

View full company profile

Therapeutic Areas

Oncology

Other Pan-Cancer Drugs

DrugCompanyPhase
Idylla POLE-POLD1 Mutation AssayBiocartisResearch
Diagnostic Matching ServiceDarwinHealthCommercial
Platform-Driven Drug Discovery & Asset PrioritizationDarwinHealthDiscovery/Pre-clinical
Companion Diagnostic Development & ValidationPangaea OncologyDevelopment/Validation